Viewing Study NCT05786768


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-25 @ 3:00 PM
Study NCT ID: NCT05786768
Status: RECRUITING
Last Update Posted: 2023-11-09
First Post: 2023-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module